These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6196636)

  • 1. Mutations resistant to bromodeoxyuridine in mouse lymphoma cells selected by repeated exposure to EMS. Characteristics of phenotypic instability and reversion to HAT resistance by 5-azacytidine.
    Nakamura N; Okada S
    Mutat Res; 1983 Nov; 111(3):353-64. PubMed ID: 6196636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation and characterization of mammalian cell lines carrying suppressible mutations.
    López-Revilla R; Martínez HG; Santos-Díaz MS
    Mol Gen Genet; 1988 Jul; 213(1):105-11. PubMed ID: 3221837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutational and pseudomutational effects of 5-bromodeoxyuridine in human lymphoblasts.
    Liber HL; Call KM; Mascioli DA; Thilly WG
    Mutat Res; 1985 Aug; 151(1):95-108. PubMed ID: 3927158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do trifluorothymidine-resistant mutants of L5178Y mouse lymphoma cells re-express thymidine kinase activity following 5-azacytidine treatment?
    Moore MM; Applegate ML; Hozier JC
    Mutat Res; 1988 Feb; 207(2):77-82. PubMed ID: 2448615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishment of a dose-response relationship for reverse mutation at the HPRT (hypoxanthine guanine phosphoribosyl transferase) locus L5178Y mouse lymphoma cells.
    Knaap AG; Meera Khan P; Simons JW
    Mutat Res; 1982 Oct; 96(2-3):259-71. PubMed ID: 7144801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotypic evolution of cells resistant to bromodeoxyuridine.
    Harris M; Collier K
    Proc Natl Acad Sci U S A; 1980 Jul; 77(7):4206-10. PubMed ID: 6933467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitation of small colony trifluorothymidine-resistant mutants of L5178Y/TK+/- mouse lymphoma cells in RPMI-1640 medium.
    Moore MM; Howard BE
    Mutat Res; 1982; 104(4-5):287-94. PubMed ID: 6810164
    [No Abstract]   [Full Text] [Related]  

  • 8. Induction of mutations in mouse lymphoma L5178Y cells by ethylmethanesulphonate, benzidine and benzo[a]pyrene.
    Henderson L; Ransome S; Brabbs C; Tinner A; Davies S
    Mutagenesis; 1990; 5 Suppl():27-34. PubMed ID: 2184317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of a nonexpressed hypoxanthine phosphoribosyltransferase allele in mutant H23 HeLa cells by agents that inhibit DNA methylation.
    Ivarie R; Morris JA
    Mol Cell Biol; 1986 Jan; 6(1):97-104. PubMed ID: 2431268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversion in thymidine kinase deficient variants of mouse lymphoma P388.
    Ruddy SM; Hickey I
    Mutat Res; 1989 Nov; 227(3):187-92. PubMed ID: 2478884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Locus specificity of mutagenicity of 2,4-diaminotoluene in both L5178Y mouse lymphoma and AT3-2 Chinese hamster ovary cells.
    Coppinger WJ; Brennan SA; Carver JH; Thompson ED
    Mutat Res; 1984 Feb; 135(2):115-23. PubMed ID: 6694660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversion analysis of mutations induced by 5-bromodeoxyuridine mutagenesis in mammalian cells.
    Kaufman ER
    Mol Cell Biol; 1985 Nov; 5(11):3092-6. PubMed ID: 3837841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular analysis of mutations at the tk locus of L5178Y mouse-lymphoma cells induced by ethyl methanesulphonate and mitomycin C.
    Davies MJ; Phillips BJ; Rumsby PC
    Mutat Res; 1993 Dec; 290(2):145-53. PubMed ID: 7694105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On the mechanism of 5-bromodeoxyuridine induction of prolactin synthesis in rat pituitary tumor cells.
    Biswas DK; Abdullah KT; Brennessel BA
    J Cell Biol; 1979 Apr; 81(1):1-9. PubMed ID: 479283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular aspects of chemical mutagenesis in L5178Y/tk +/- mouse lymphoma cells.
    Clive D; Glover P; Applegate M; Hozier J
    Mutagenesis; 1990 Mar; 5(2):191-7. PubMed ID: 2188074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The induction and characterization of mouse lymphoma L5178Y cell lines resistant to 1-beta-d-arabinofuranosylcytosine.
    Rogers AM; Hill R; Lehmann AR; Arlett CF; Burns VW
    Mutat Res; 1980 Jan; 69(1):139-48. PubMed ID: 7360142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TFT and 6TG resistance of mouse lymphoma cells to analogs of azacytidine.
    McGregor DB; Brown AG; Cattanach P; Shepherd W; Riach C; Daston DS; Caspary WJ
    Carcinogenesis; 1989 Nov; 10(11):2003-8. PubMed ID: 2478309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bromodeoxyuridine resistance: thymidine transport and phosphorylation in Friend leukemia cells.
    Keller P; Zownir O; Morrow J
    Mutat Res; 1984 Mar; 126(1):53-62. PubMed ID: 6583506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multi-endpoint genotoxic assay using L5178Y (Tk(+/-) -3.7.2c) cells.
    Ogawa I; Furukawa S; Abe M; Tanaka Y; Hayashi S; Usuda K
    J Toxicol Sci; 2009 Oct; 34(5):547-53. PubMed ID: 19797863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular analysis of in vivo mutations induced by N-ethyl-N-nitrosourea in the autosomal Tk and the X-linked Hprt genes of mouse lymphocytes.
    Dobrovolsky VN; Chen T; Heflich RH
    Environ Mol Mutagen; 1999; 34(1):30-8. PubMed ID: 10462721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.